Complement and microglia mediate early synapse loss in Alzheimer mouse models
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index; 21 of the 28 sources its claims cite were checked for support.
Abstract
Too much cleaning up: The complement system and microglia seek out and destroy unwanted cellular debris for the peripheral immune system as well as excess synapses in the developing brain. Hong et al. now show how the system may go haywire in adults early in the progression toward Alzheimer's disease (AD). Aberrant synapse loss is an early feature of Alzheimer's and correlates with cognitive decline. In mice susceptible to AD, complement was associated with synapses, and microglial function was required for synapse loss. The authors speculate that aberrant activation of this “trash disposal” system underlies AD pathology. Science , this issue p. 712
Overview
CoChat Summary
TL;DR
In Alzheimer mouse models, classical complement proteins C1q and C3 increase and localize to synapses before plaques, and blocking C1q, C3, or microglial CR3 reduces early synapse loss. Soluble Aβ oligomers drive microglial engulfment of synaptic material through a CR3-dependent pathway, suggesting reactivation of developmental synaptic pruning in early AD.
Key findings
- J20 hAPP mice showed significant hippocampal synapse loss at 3–4 months, before plaque deposition; loss occurred in CA1, CA3, and dentate gyrus at 3 months but not in striatum, and was not seen at 1 month.
- C1q was elevated in J20 brains as early as 1 month, region-specifically in hippocampus and frontal cortex, and colocalized with PSD95-positive puncta; Compound E reduced soluble Aβ and C1q deposition, while oligomeric Aβ—but not monomeric Aβ or vehicle—induced C1q deposition and synaptic colocalization.
- Oligomeric Aβ induced synapse loss within 72 h in WT mice but not in C1qa knockout mice; anti-C1q antibody ANX-M1 prevented oAβ-induced synapse loss and LTP impairment, and APP/PS1xC3 KO mice did not show the synapse loss seen in 4-month APP/PS1 hippocampus.
- Microglial CD68 increased in J20 hippocampus and after oAβ; oAβ increased internalized Homer-GFP in microglia, failed to do so in CR3 KO mice, and induced hippocampal synapse loss in WT but not CR3 KO mice.
Methods
- Mouse models included J20 hAPP, APP/PS1, C1qa KO, C3 KO, CR3 KO, and Homer-GFP mice, with WT littermates and ages including 1 month, 3–4 months, and P21.
- Synapse quantification used super-resolution structured illumination microscopy, confocal imaging, and electron microscopy with colocalized pre- and postsynaptic puncta markers including synaptophysin/PSD95, synaptotagmin/homer, and synapsin/PSD95; C1q and C3 colocalization with PSD95 was also measured.
- Interventions included Compound E, intracerebroventricular or tail vein injections of soluble Aβ oligomers, monomers, or vehicle, anti-C1q antibody ANX-M1 or IgG control, acute hippocampal slice LTP recordings, and an in vivo synaptic engulfment assay.
Limitations
- The paper states that specific synaptic C1q receptors are not yet known and that oAβ and C1q may act indirectly through cytokines such as TGFβ, microglial or astrocytic activation, or other pathways including MHCI/PirB.
- The paper states that the complement pathway may not be involved in all pathological routes to AD, including plaque-associated synapse loss, and that future studies are needed to examine plaque-associated synapse loss and other synaptopathies such as tauopathies and Huntington’s disease.
- Evident from the text: the findings are from mouse models and acute hippocampal slices, not human AD tissue or clinical trials, and the study focuses on early pre-plaque mechanisms rather than established plaque-associated neuropathology.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Valid · 0 Not valid · 2 Not checked · 48 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [5] Stevens B The classical complement cascade mediates CNS synapse elimination. Cell 2007 131 1164 1178 18083105 source
The Results report C1q localized to synapses in the developing dLGN during synaptic pruning and relocalized to adult retinal synapses in early glaucoma, before significant synapse loss. The Discussion likewise places synaptic C1q relocalization before or concurrent with synapse loss in the glaucoma model. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites [27] Stephan AH Barres BA Stevens B The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci 2012 35 369 389 22715882 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“suggesting that the engulfed synapses are internalized into lysosomal compartments in a manner similar to developmental synaptic pruning (6).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [6] Schafer DP Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner. Neuron 2012 74 691 705 22632727 PMC3528177 source
The Results section, “Microglia engulf RGC inputs during a period of active synaptic pruning” (page unavailable), reports that most engulfed RGC inputs colocalized with microglial lysosomal compartments. The Results section, “Microglia engulf presynaptic elements specific to RGCs” (page unavailable), also identifies an RGC presynaptic marker within microglial lysosomes, supporting the proposed similarity to developmental synaptic pruning. (LLM, conf=0.94)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Quantification of colocalized pre- and postsynaptic puncta (synaptophysin and PSD95 (Fig. 1A); synaptotagmin and homer (figs. S1A-D)) revealed a significant loss of synapses in J20 hippocampus at 3-4 months old (mo), an age that precedes plaque deposition (11, 12).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [11] Mucke L High-Level Neuronal Expression of Abeta 1-42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation. Journal of Neuroscience 2000 20 4050 10818140 PMC6772621 source
The citation is attached to the statement that 3–4 months precedes plaque deposition, not to the citing authors’ synapse measurements. In “Effects of hAPP mutations on formation of amyloid plaques” (Fig. 4; page not provided), the paper assesses mice at 2–4 months and reports amyloid deposition in APP Sw,Ind mice at 5–7 months; the paper identifies J20 as an APP Sw,Ind line. (LLM, conf=0.91)
- Supportedcites [12] Hong S Dynamic Analysis of Amyloid -Protein in Behaving Mice Reveals Opposing Changes in ISF versus Parenchymal A during Age-Related Plaque Formation. Journal of Neuroscience 2011 31 15861 15869 22049429 PMC3227224 source
The citation follows the statement that 3–4 months precedes plaque deposition, rather than the citing authors’ own synapse measurements. The Results section (page unavailable) identifies approximately 3-month-old J20 mice as pre-plaque and describes 3–7-month-old mice as plaque-free. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Genome-wide association studies (GWAS) implicate microglia and complement-related pathways in AD (1).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [1] Hong S Dissing-Olesen L Stevens B New insights on the role of microglia in synaptic pruning in health and disease. Curr Opin Neurobiol 2016 doi:10.1016/j.conb.2015.12.004 PMC5479435 26745839 source
The Introduction says GWAS and integrated network studies identify immune-related AD risk pathways implicating microglia. The section on microglia–synapse dysfunction identifies GWAS variants CLU and CR1, both related to complement. Page numbers are not provided in our copy. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“C1q was also similarly increased in hippocampus of another model of AD, the APP/PS1 mice (15) (Fig. S2C).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [15] Jankowsky JL Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet 2004 13 159 170 14645205 source
The citation identifies the APP/PS1 mouse model, while the citing document points to its own Fig. S2C for the C1q increase. Figure 2 (p. 4) describes APPswe/PS1 double-transgenic mice and shows hippocampal amyloid pathology in that model. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
48 more claims · 5 with their cited sources checked
Create a free account to see all 66 claims and every source verdict.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“increasing evidence demonstrate that immune signaling may not just be a consequence of protein aggregation in the brain, but that it actually causes the buildup of aggregates at the earliest stages of the disease process.15–17”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [15]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In neurodegeneration, the complement pathway is activated, and inhibiting the complement proteins C1q or C3 results in less neuroinflammation, Aβ plaques and synapse loss29,30.”
From Exercise plasma boosts memory and dampens brain inflammation via clusterin (2021) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Before the onset of Aβ deposition, microglia engulf synapses opsonized with the complement factors C1q and C3 upon CR3-mediated recognition of C3 (121).”
From Microglia in Alzheimer's disease (2017) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lack of C1q, C3, or CR3 curbed microglia activation and synaptic loss during amyloid plaque deposition.”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [139]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inappropriate control of the classical complement cascade causes unresolvable inflammation and disease (Hong et al. , 2016; Hansen, Hanson and Sheng, 2018; Morgan, 2018).”
From Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s Disease (2020) · cites this paper as Hong et al., 2016
Experimental — accuracy not yet measured
70 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Cited work 10.1038/nn.3560 · retracted 2022-01-13 · notice 10.1038/s41593-021-00877-7 · this paper published 2016-05-06
Citations
Cites
1 retracted
Bialas, A. R., & Stevens, B. (2013) · Nature Neuroscience · doi:10.1038/nn.3560 · Cited by 519 · cited 2×
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Self-citationRetractedAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · cited 1×
“Synaptic deficits occur in early AD and mild cognitively impaired patients before onset of plaques and are some of the first signs of the neuronal degenerative process (4, 23-25).”
Self-citationTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationThe Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313 · cited 4×
“Although specific receptors for C1q at synapses are not yet known, C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
InfluentialSelf-citationIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 1×
“S11), indicating they are resident cells (22).”
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 3×
“S4), long before Aβ plaques deposit (11, 12), raising the question of whether C1q increase in these pre-plaque brains is dependent on soluble Aβ levels.”
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Cited by
Items 701–800 of 3,349
Boza-Serrano, A., Vrillon, A., Minta, K., Paulus, A., Camprubí-Ferrer, L., Garcia, M., Andreasson, U., Antonell, A., Wennström, M., Gouras, G., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02469-6 · Cited by 66
“Synaptic dysfunction is an early feature in AD, and recent studies suggest that microglia-mediated synapse removal could be a contributing factor [22].”
Central nervous system diseases related to pathological microglial phagocytosis
Wang, K., Li, J., Zhang, Y., Huang, Y., Chen, D., Shi, Z., Smith, A. D., Li, W., & Gao, Y. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13619 · Cited by 69
Discovery and Validation of Key Biomarkers Based on Immune Infiltrates in Alzheimer’s Disease
Liu, Z., Li, H., & Pan, S. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.658323 · Cited by 75
“The previous research demonstrated that C1q is highly correlated with Aβ deposition and activates microglia phagocytosis, which, in turn, leads to synapse loss (Hong et al., 2016).”
BackgroundWang, X., & Li, L. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.722028 · Cited by 76
Synaptic pruning of murine adult-born neurons by microglia depends on phosphatidylserine
Kurematsu, C., Sawada, M., Ohmuraya, M., Tanaka, M., Kuboyama, K., Ogino, T., Matsumoto, M., Oishi, H., Inada, H., Ishido, Y., et al. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20202304 · Cited by 67
The Importance of Complement-Mediated Immune Signaling in Alzheimer’s Disease Pathogenesis
Batista, A. F., Khan, K. A., Papavergi, M.-T., & Lemere, C. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020817 · Cited by 65
“Moreover, the role of complement in the inflammatory response observed in AD has also been widely explored in various reports [22,23,45,63,109–111].”
BackgroundInfluentialSelf-citationMicroglia in Ischemic Stroke: Pathogenesis Insights and Therapeutic Challenges
Shui, X., Chen, J., Fu, Z., Zhu, H., Tao, H., & Li, Z. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s461795 · Cited by 85
Fagan, K., Crider, A., Ahmed, A. O., & Pillai, A. (2017) · Complex Psychiatry · doi:10.1159/000465523 · Cited by 66
Shedding Light on the Dark Side of the Microglia
St-Pierre, M.-K., Šimončičová, E., Bögi, E., & Tremblay, M.-È. (2020) · ASN Neuro · doi:10.1177/1759091420925335 · Cited by 66
“The connection between systemic inflammation and microglial response in sickness behavior has been extensively covered (Dantzer et al., 2008; Hoogland et al., 2015).”
BackgroundImpaired αVβ8 and TGFβ signaling lead to microglial dysmaturation and neuromotor dysfunction
Arnold, T. D., Lizama, C. O., Cautivo, K. M., Santander, N., Lin, L., Qiu, H., Huang, E. J., Liu, C., Mukouyama, Y.-S., Reichardt, L. F., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20181290 · Cited by 67
Kiss, T., Nyúl-Tóth, Á., DelFavero, J., Balasubramanian, P., Tarantini, S., Faakye, J., Gulej, R., Ahire, C., Ungvari, A., Yabluchanskiy, A., et al. (2022) · GeroScience · doi:10.1007/s11357-022-00521-7 · Cited by 66
Clearance by Microglia Depends on Packaging of Phagosomes into a Unique Cellular Compartment
Villani, A., Benjaminsen, J., Moritz, C., Henke, K., Hartmann, J., Norlin, N., Richter, K., Schieber, N. L., Franke, T., Schwab, Y., et al. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.02.014 · Cited by 70
Neuromodulation of Glial Function During Neurodegeneration
Stevenson, R., Samokhina, E., Rossetti, I., Morley, J. W., & Buskila, Y. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00278 · Cited by 72
“Indeed, abnormalities in synaptic pruning by microglia have been associated with the cognitive decline that accompanies many neurodegenerative disorders such as Alzheimer’s disease (AD; Hong et al., 2016a).”
BackgroundGo, J., Chang, D.-H., Ryu, Y.-K., Park, H.-Y., Lee, I.-B., Noh, J.-R., Hwang, D. Y., Kim, B.-C., Kim, K.-S., & Lee, C.-H. (2021) · Nutrition Research · doi:10.1016/j.nutres.2020.12.010 · Cited by 67
Heurich, M., Föcking, M., Mongan, D., Cagney, G., & Cotter, D. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01197-9 · Cited by 73
Mercurio, D., Fumagalli, S., Schafer, M. K.-H., Pedragosa, J., Ngassam, L. D. C., Wilhelmi, V., Winterberg, S., Planas, A. M., Weihe, E., & De Simoni, M.-G. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.820127 · Cited by 65
“On the contrary, microglia may also develop harmful functions, thus, driving to unwanted synaptic pruning in neurodegenerative conditions (Hong et al., 2016a,b).”
BackgroundImpairments of glutamatergic synaptic transmission in Alzheimer’s disease
Zott, B., & Konnerth, A. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.03.013 · Cited by 70
Zhang, H., Jiang, W., Zhao, Y., Song, T., Xi, Y., Han, G., Jin, Y., Song, M., Bai, K., Zhou, J., et al. (2022) · Nano Letters · doi:10.1021/acs.nanolett.2c00191 · Cited by 65
Remodeling of lipid bodies by docosahexaenoic acid in activated microglial cells
Tremblay, M.-E., Zhang, I., Bisht, K., Savage, J. C., Lecours, C., Parent, M., Titorenko, V., & Maysinger, D. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0580-0 · Cited by 66
“Interestingly, inhibition of microglial phagocytosis has been shown to prevent inflammatory neuronal death [74] and synaptic loss in aging and Alzheimer’s disease in vivo [75, 76].”
Mastroeni, D., Nolz, J., Sekar, S., Delvaux, E., Serrano, G., Cuyugan, L., Liang, W. S., Beach, T. G., Rogers, J., & Coleman, P. D. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.10.019 · Cited by 66
“…may play significant roles in nervous 329 system development (Frost and Schafer, 2016; Schafer and Stevens, 2015), synaptic plasticity 330 (Hong et al., 2016; Kettenmann et al., 2013; Paolicelli et al., 2011; Perry and O'Connor, 2010; 331 Schafer and Stevens, 2015), and neurogenesis (De…”
BackgroundMicroglia Mediate HIV-1 gp120-Induced Synaptic Degeneration in Spinal Pain Neural Circuits
Ru, W., Liu, X., Bae, C., Shi, Y., Walikonis, R. S., Chung, J. M., & Tang, S. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.2851-18.2019 · Cited by 69
“…synapses, complement components C1q and C3 sequentially translocate to the synapses to act as “eat-me” signals (Schafer et al., 2012), which bind to the microglial receptor CR3 to stimulate synapse elimination (Stevens et al., 2007; Schafer et al., 2012; Hong et al., 2016b; Vasek et al., 2016).”
BackgroundModulation of Glial Function in Health, Aging, and Neurodegenerative Disease
Hanslik, K. L., Marino, K. M., & Ulland, T. K. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.718324 · Cited by 72
Bi, Q., Wang, C., Cheng, G., Chen, N., Wei, B., Liu, X., Li, L., Lu, C. C., He, J., Weng, Y., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.06.018 · Cited by 69
Lucente, J. D., Persico, G., Zhou, Z., Jin, L., Ramsey, J. J., Rutkowsky, J. M., Montgomery, C. B., Tomilov, A. A., Kim, K., Giorgio, M., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-05860-z · Cited by 73
“Microglia are intimately involved with synaptic plasticity, and microglial activation/in fl ammation has been proposed as a potential mechanism in Alzheimers 44 .”
Wu, J., Hocevar, M., Foss, J. F., Bie, B., & Naguib, M. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.05.044 · Cited by 72
Györffy, B. A., Tóth, V., Török, G., Gulyássy, P., Kovács, R. Á., Vadászi, H., Micsonai, A., Tóth, M. E., Sántha, M., Homolya, L., et al. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03468-0 · Cited by 70
Barclay, K. M., Abduljawad, N., Cheng, Z., Kim, M. W., Zhou, L., Yang, J., Rustenhoven, J., Mazzitelli, J. A., Smyth, L. C. D., Kapadia, D., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.05.005 · Cited by 65
Makarava, N., Chang, J. C.-Y., Molesworth, K., & Baskakov, I. V. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104783 · Cited by 64
Role of microglia in fungal infections of the central nervous system
Koutsouras, G. W., Ramos, R. L., & Martinez, L. R. (2016) · Virulence · doi:10.1080/21505594.2016.1261789 · Cited by 67
“in microglia and abundantly found in brain tissue, playing a major role in neurodegenerative diseases such as Alzheimer’s disease.(89) This is an exciting and promising area of investigation considering the predilection of C.”
BackgroundMicroglia dynamics in adolescent traumatic brain injury
Eyolfson, E., Khan, A. C., Mychasiuk, R., & Lohman, A. W. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01994-z · Cited by 79
“However, Hong and associates determined that in rodent models of AD, C1q, and C3 are expressed on synapses before β-amyloid plaque formation and associated synaptic loss, while blockade of the complement cascade in this system protected against synaptic loss [173].”
BackgroundResultThe Role of Astrocytes in Synapse Loss in Alzheimer's Disease: A Systematic Review
Hulshof, L. A., van Nuijs, D., Hol, E. M., & Middeldorp, J. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.899251 · Cited by 64
Lv, Z., Chen, L., Chen, P., Peng, H., Rong, Y., Hong, W., Zhou, Q., Li, N., Li, B., Paolicelli, R. C., et al. (2024) · Neuron · doi:10.1016/j.neuron.2023.12.003 · Cited by 69
de Souza, D. G., Almeida, R. F., Souza, D. O., & Zimmer, E. R. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.04.002 · Cited by 79
A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s disease
the MODEL-AD Consortium, Preuss, C., Pandey, R., Piazza, E., Fine, A., Uyar, A., Perumal, T., Garceau, D., Kotredes, K. P., Williams, H., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00412-5 · Cited by 63
“This is in line with multiple studies which showed that the profound loss of synapses at the early stages of AD can be prevented by blocking activation of the complement cascade through C1q depletion in the mouse [24, 25].”
ResultComplement-associated loss of CA2 inhibitory synapses in the demyelinated hippocampus impairs memory
Ramaglia, V., Dubey, M., Malpede, A. M., Petersen, N., de Vries, S. I., Ahmed, S. M., Lee, D. S. W., Schenk, G. J., Gold, S. M., Huitinga, I., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02338-8 · Cited by 66
Psychedelic‐inspired approaches for treating neurodegenerative disorders
Saeger, H. N., & Olson, D. E. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15544 · Cited by 74
“Elevated levels of C1q and C3 have been observed in AD mouse models (Hong et al., 2016; Stephan et al., 2012), and Aβ species can lead to C1 activation (Tacnet- Delorme et al., 2001).”
BackgroundInfluentialModulation of C5a–C5aR1 signaling alters the dynamics of AD progression
Carvalho, K., Schartz, N. D., Balderrama-Gutierrez, G., Liang, H. Y., Chu, S., Selvan, P., Gómez-Arboledas, Á., Petrisko, T. J., Fonseca, M. I., Mortazavi, A., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02539-2 · Cited by 64
“Deletion of C1q, C3, or CR3 (CD11b/CD18) reduces microglial engulfment of synapses (68, 71, 72) and protects against memory deficits in aged mice (73) and in models of AD (70, 74) and other neurological disorders (reviewed in (75)).”
BackgroundFerroptosis of Microglia in Aging Human White Matter Injury
Adeniyi, P. A., Gong, X., MacGregor, E., Degener-O’Brien, K., McClendon, E., Garcia, M., Romero, O., Russell, J., Srivastava, T., Miller, J. A., et al. (2023) · Annals of Neurology · doi:10.1002/ana.26770 · Cited by 72
Neuroimmune Response in Ischemic Preconditioning
McDonough, A., & Weinstein, J. R. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0465-z · Cited by 67
“Astrocytes are capable of synthesizing essentially all complement activation proteins, regulatory molecules, and receptors [21, 111].”
BackgroundComplement Receptors in Myeloid Cell Adhesion and Phagocytosis
Dustin, M. L. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0034-2016 · Cited by 63
“In mouse models of Alzheimer ’ s disease, C1q, C3, and CR3 expressed by microglial cells are required for destruction of synapses early in the disease process (76).”
BackgroundGlia in Neurodegeneration: The Housekeeper, the Defender and the Perpetrator
Sheeler, C. A., Rosa, J. S., Ferro, A., McAdams, B. D., Borgenheimer, E., & Cvetanović, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239188 · Cited by 63
“Enhanced microglial activation via the NF-κB pathway, or other proinflammatory pathways, can impact the overall neural architecture in several ways: by affecting neuronal function through direct signaling and through release of proinflammatory cytokines [28], by regulating the inflammatory state of non-neuronal cells…”
Background(ADNI), A. D. N. I., Kleineidam, L., Chouraki, V., Próchnicki, T., van der Lee, S. J., Madrid-Márquez, L., Wagner-Thelen, H., Karaca, I., Weinhold, L., Wolfsgruber, S., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02138-6 · Cited by 62
B lymphocytes ameliorate Alzheimer’s disease-like neuropathology via interleukin-35
Feng, W., Zhang, Y., Ding, S., Chen, S., Wang, T., Wang, Z., Zou, Y., Sheng, C., Chen, Y., Pang, Y., et al. (2023) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2022.11.012 · Cited by 62
Chen, M., & Xia, W. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200110 · Cited by 65
“A2M is genetically associated with AD [46], and complement C3 is involved in synaptic dysfunction in AD [47].”
BackgroundMicroglial responses to peripheral type 1 interferon
Aw, E., Zhang, Y., & Carroll, M. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02003-z · Cited by 62
“It is increasingly appreciated that the complement pathway might play a significant role in the pathogenesis of several neurodegenerative [14] and neuropsychiatric [16] diseases and that it is also a driver of synapse loss in viral infection-associated cognitive decline [25].”
BackgroundInfluentialThe Ins and Outs of Central Nervous System Inflammation—Lessons Learned from Multiple Sclerosis
Ramaglia, V., Rojas, O. L., Naouar, I., & Gommerman, J. L. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-093019-124155 · Cited by 79
Microglial Function and Regulation during Development, Homeostasis and Alzheimer’s Disease
Casali, B. T., & Reed-Geaghan, E. G. (2021) · Cells · doi:10.3390/cells10040957 · Cited by 78
“Microglia-specific complement proteins and receptors play key roles in exacerbating disease, especially early in disease where C1q promotes Aβ-induced synapse elimination in the hippocampus and subsequent behavioral impairments [70].”
BackgroundKim, S., Kim, D. K., Jeong, S., & Lee, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115894 · Cited by 75
“In addition, microglia and astrocytes have been documented to eliminate synapses via their phagocytic activity [50,51], and activated microglia and astrocytes target neurons to remove synaptic connections and induce neuronal death in vitro and in vivo experimental models of AD [51,52].”
BackgroundChocrón, E. S., Munkácsy, E., Kim, H. S., Karpowicz, P., Jiang, N., Skike, C. E. V., DeRosa, N., Banh, A. Q., Palavicini, J. P., Wityk, P., et al. (2022) · Science Advances · doi:10.1126/sciadv.abk2252 · Cited by 70
Pettas, S., Karagianni, K., Kanata, Ε., Chatziefstathiou, A., Christoudia, N., Xanthopoulos, K., Sklaviadis, T., & Dafou, D. (2022) · Cells · doi:10.3390/cells11152383 · Cited by 76
“Although these clusters derive from distinct functional categories, similarities between them support the idea that gene expression during development matches the transcriptional profile of aging and neurodegeneration through reactivation of certain genes [49].”
BackgroundQiu, Y., Shen, X., Ravid, O., Atrakchi, D., Rand, D., Wight, A. E., Kim, H.-J., Liraz-Zaltsman, S., Cooper, I., Schnaider Beeri, M., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2218915120 · Cited by 61
“Spp1 mice with 5XFAD mice as a previously described strategy for breeding genetic-modified AD mouse models featuring amyloid pathology (5, 19, 39, 50).”
Yin, H., Ju, Z., Zheng, M., Zhang, X., Zuo, W., Wang, Y., Ding, X., Zhang, X., Peng, Y., Li, J., et al. (2023) · PLOS Biology · doi:10.1371/journal.pbio.3002017 · Cited by 62
Metabolic Syndrome and the Cellular Phase of Alzheimer's Disease
Pugazhenthi, S. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.016 · Cited by 70
Microglial Interferon Signaling and White Matter
McDonough, A., Lee, R. V., & Weinstein, J. R. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2307-8 · Cited by 60
Hinkle, J. J., Olschowka, J. A., Love, T. M., Williams, J. P., & O’Banion, M. K. (2019) · Scientific Reports · doi:10.1038/s41598-019-55366-6 · Cited by 61
Breaking Boundaries: Chronic Diseases and the Frontiers of Immune Microenvironments
Li, G., Wan, Y., Jiao, A., Jiang, K., Cui, G., Tang, J., Yu, S., Hu, Z., Zhao, S., Yi, Z., et al. (2025) · Med Research · doi:10.1002/mdr2.70007 · Cited by 63
Microglia and Parkinson's disease: footprints to pathology
Lazdon, E., Stolero, N., & Frenkel, D. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02154-6 · Cited by 63
He, X., Xu, J., Li, G., Li, M., Li, L., Pei, Z., Zhang, L., & Hu, X. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03072-x · Cited by 70
The roles of astrocytic phagocytosis in maintaining homeostasis of brains
Lee, S. Y., & Chung, W. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.12.007 · Cited by 66
Illouz, T., Biragyn, A., Iulita, M. F., Aguilar, L. F., Dierssen, M., Toma, I. D., Antonarakis, S. E., Yu, E. Y., Hérault, Y., Potier, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.621440 · Cited by 76
“…is associated with multiple pathologies, such as improper pulmonary clearance of Streptococcus pneumoniae (131), pathogenesis of age-related kidney injury (132), and microglia-mediated synapse loss in amyloid pathologies (133), which may further contribute to accelerating AD pathogenesis.”
Jiang, D., Burger, C. A., Akhanov, V., Liang, J. H., Mackin, R. D., Albrecht, N. E., Andrade, P., Schafer, D. P., & Samuel, M. A. (2022) · Immunity · doi:10.1016/j.immuni.2022.10.018 · Cited by 60
Zhang, J., Wang, J., Xu, X., You, Z., Huang, Q., Huang, Y., Guo, Q., Guan, Y., Zhao, J., Liu, J., et al. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231153730 · Cited by 62
“In AD mouse models, complement and microglia mediated early synapse loss.(5) Diffusible oligomeric assemblies of the amyloid b protein could cause synaptic dysfunction.”
BackgroundJiang, J., Zou, Y., Xie, C., Yang, M., Tong, Q., Yuan, M., Pei, X., Deng, S., Tian, M., Xiao, L., et al. (2023) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2023.08.023 · Cited by 60
Complement-mediated synapse loss in Alzheimer’s disease: mechanisms and involvement of risk factors
Wen, L., Bi, D., & Shen, Y. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.11.010 · Cited by 71
Minogue, A. M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.02.008 · Cited by 65
Complement-Related Regulates Autophagy in Neighboring Cells
Lin, L., Rodrigues, F. S. L. M., Kary, C. S., Contet, A., Logan, M. A., Baxter, R. H. G., Wood, W., & Baehrecke, E. H. (2017) · Cell · doi:10.1016/j.cell.2017.06.018 · Cited by 63
Jiao, H., Rutar, M., Fernando, N., Yednock, T. A., Sankaranarayanan, S., Aggio‐Bruce, R., Provis, J. M., & Natoli, R. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0278-0 · Cited by 67
“Moreover, C1q is involved in the elimination of synapses in a mouse model of AD, and blockade of C1q significantly preserved synaptic function [41, 42].”
BackgroundSleep and circadian rhythm disruption and stress intersect in Alzheimer's disease
Phan, T. X., & Malkani, R. G. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.10.001 · Cited by 60
Long-term, West Nile virus-induced neurological changes: A comparison of patients and rodent models
Fulton, C. M., Beasley, D. W. C., Bente, D. A., & Dineley, K. T. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100105 · Cited by 67
Ma, S.-X., Seo, B. A., Kim, D., Xiong, Y., Kwon, S., Brahmachari, S., Kim, S., Kam, T., Nirujogi, R. S., Kwon, S. H., et al. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c01002 · Cited by 66
Hamilton, L. K., Moquin-Beaudry, G., Mangahas, C. L., Pratesi, F., Aubin, M., Aumont, A., Joppé, S. E., Légiot, A., Vachon, A., Plourde, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29506-y · Cited by 66
“They also disproportionately express AD risk genes 30 and are implicated in AD-associated synapse loss 29,31 , making them central players during AD pathogenesis 32,33 .”
InfluentialDroplet-based transcriptome profiling of individual synapses
Niu, M., Cao, W., Wang, Y., Zhu, Q., Luo, J., Wang, B., Zheng, H., Weitz, D. A., & Zong, C. C. (2023) · Nature Biotechnology · doi:10.1038/s41587-022-01635-1 · Cited by 67
Avila, J., Llorens-Martín, M., Pallas-Bazarra, N., Bolós, M., Perea, J. R., Rodríguez-Matellán, A., & Hernández, F. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00626 · Cited by 59
“Microglia participate in the elimination of synapses—a process known as synaptic pruning (Paolicelli et al., 2011; Schafer et al., 2012), which takes place via complement activation (Hong et al., 2016; Lui et al., 2016).”
BackgroundCo‐Culture of Neurons and Microglia
Roqué, P. J., & Costa, L. G. (2017) · Current Protocols in Toxicology · doi:10.1002/cptx.32 · Cited by 60
Novel targets in Alzheimer’s disease: A special focus on microglia
Balducci, C., & Forloni, G. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.017 · Cited by 66
Xin, Y.-R., Jiang, J.-X., Hu, Y., Pan, J.-P., Mi, X.-N., Gao, Q., Xiao, F., Zhang, W., & Luo, H.-M. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00279 · Cited by 60
“…been reported to be elevated in Frontiers in Aging Neuroscience | www.frontiersin.org 7 November 2019 | Volume 11 | Article 279 specific brain regions in early stage AD, prior to the formation of overt plaques, which promotes a CR3-dependent microglial engulfment of synapses (Hong et al., 2016).”
BackgroundInfluentialLi, S., Cai, Z., Zhang, W., Holden, D., Lin, S.-F., Finnema, S. J., Shirali, A., Ropchan, J., Carre, S., Mercier, J., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04357-w · Cited by 59
Self-citationGlial smog: Interplay between air pollution and astrocyte-microglia interactions
Gómez‐Budia, M., Konttinen, H., Saveleva, L., Korhonen, P., Jalava, P., Kanninen, K. M., & Malm, T. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104715 · Cited by 63
Mechanisms of microglia-mediated synapse turnover and synaptogenesis
Ball, J. B., Green‐Fulgham, S. M., & Watkins, L. R. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102336 · Cited by 67
Wangler, L. M., & Godbout, J. P. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.08.008 · Cited by 66
The complement system in neurodegenerative diseases
Nimmo, J., Byrne, R. A. J., Daskoulidou, N., Watkins, L. M., Carpanini, S. M., Zelek, W. M., & Morgan, B. P. (2024) · Clinical Science · doi:10.1042/cs20230513 · Cited by 61
“The demonstration that A β oligomers directly injected into mouse brain triggered complement activation and synapse loss, prevented by administration of C1q blocking antibody, implicated complement in amyloid-induced pathology [71].”
BackgroundHan, Q.-Q., Shen, S.-Y., Liang, L., Chen, X., & Yu, J. M. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.04.018 · Cited by 72
Sex bias in MHC I-associated shaping of the adaptive immune system
Schneider‐Hohendorf, T., Görlich, D., Savola, P., Kelkka, T., Mustjoki, S. M., Groß, C. C., Owens, G. C., Klotz, L., Dornmair, K., Wiendl, H., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716146115 · Cited by 73
“Even in psychological disorders such as major depression (26) and in neurodegenerative diseases such as Alzheimer’s, recent studies have shown immune system involvement (27) and sex bias (28).”
BackgroundSwartzlander, D. B., Propson, N. E., Roy, E. R., Saito, T., Saido, T., Wang, B., & Zheng, H. (2018) · JCI Insight · doi:10.1172/jci.insight.121109 · Cited by 58
Dual dose-dependent effects of fingolimod in a mouse model of Alzheimer’s disease
Carreras, I., Aytan, N., Choi, J., Tognoni, C. M., Kowall, N. W., Jenkins, B. G., & Dedeoglu, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-47287-1 · Cited by 60
Sabogal-Guáqueta, A. M., Marmolejo-Garza, A., de Pádua, V. P., Eggen, B., Boddeke, E., & Dolga, A. M. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101805 · Cited by 58
“Activation of this pathway is pathological in AD since it reduces healthy synapses and correlates with cognitive decline (Hong et al., 2016).”
Wang, L., Nykänen, N.-P., Western, D., Gorijala, P., Timsina, J., Li, F., Wang, Z., Ali, M., Yang, C., Marquié, M., et al. (2023) · doi:10.1101/2023.06.14.23291409 · Cited by 59
Microglial clearance of focal apoptotic synapses
Nonaka, S., & Nakanishi, H. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134317 · Cited by 58
Quantitative phosphoproteomics uncovers dysregulated kinase networks in Alzheimer’s disease
Morshed, N., Lee, M. J., Rodriguez, F. H., Lauffenburger, D. A., Mastroeni, D., & White, F. M. (2021) · Nature Aging · doi:10.1038/s43587-021-00071-1 · Cited by 58
Yi-Bin, W., Xiang, L., Bing, Y., Qi, Z., Fei-Tong, J., Minghong, W., Xiangxiang, Z., Le, K., Yan, L., Ping, S., et al. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-04765-1 · Cited by 58
“CA-SBEβCD NPs administration alleviates the abnormal aggregation of glia in the brains of APP/PS1 mice Considering the anti-inflammatory properties of CA and the deleteriousness of inflammation in promoting aberrant synaptic pruning and facilitating Aβ pathology [37], we investigated the effects of CA-SBEβCD NPs treat…”
BackgroundFaridar, A., Vasquez, M., Thome, A. D., Yin, Z., Xuan, H., Wang, J. H., Wen, S., Li, X., Thonhoff, J. R., Zhao, W., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01447-z · Cited by 72
Zhao, X., Sun, J., Li, X., She, L., Li, L., Tang, H., Zeng, Y., Chen, F., Han, X., Ye, S., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.81900 · Cited by 66
“have demonstrated that microglia engulf abnormal synapses when challenged with oligomeric Aβ [39].”
BackgroundThe Role of Glial Cells in Synaptic Dysfunction: Insights into Alzheimer's Disease Mechanisms
Yu, Y., Chen, R., Mao, K., Deng, M., & Li, Z. (2023) · Aging and Disease · doi:10.14336/ad.2023.0718 · Cited by 66
“In multiple AD mouse models, including J20 and APP/PS1, soluble Aβ leads to the tagging of C1q at hippocampal synapses prior to plaque formation [47].”
BackgroundMacrophages and microglia in inflammation and neuroinflammation underlying different pain states
Ouyang, C., Luo, X., & Ji, R. (2023) · Medical Review · doi:10.1515/mr-2023-0034 · Cited by 74
“Microglia play an important role in inducing and maintaining neuroin fl ammation in the CNS, driving chronic pain and its comorbidities (e.g., depression, anxiety, and cognitive decline) [4, 5, 43, 44].”
BackgroundA story of birth and death: Insights into the formation and dynamics of the microglial population
Askew, K., & Gomez-Nicola, D. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.03.009 · Cited by 57
Exercise prevents obesity-induced cognitive decline and white matter damage in mice
Graham, L. C., Grabowska, W. A., Chun, Y., Risacher, S. L., Philip, V. M., Saykin, A. J., Rizzo, S. J. S., & Howell, G. R. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.03.018 · Cited by 59
“Data from this study, our (Graham et al., 2016; Soto et al., 2015) and other previous studies (Hong et al., 2016; Shi et al., 2017; Stephan et al., 2013) predict that myeloid cells play an important role in brain health during aging, obesity, and neurodegenerative diseases (reviewed in the study by…”
Wang, L., Nykänen, N.-P., Western, D., Gorijala, P., Timsina, J., Li, F., Wang, Z., Ali, M., Yang, C., Liu, M., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00687-4 · Cited by 58
Behavioral and neuropsychiatric disorders in Alzheimer's disease
Cortés, N., Andrade, V., & Maccioni, R. B. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-180005 · Cited by 57
Platelet biomarkers for a descending cognitive function: A proteomic approach
Yu, H., Liu, Y., He, B., He, T., Chen, C., He, J., Yang, X., & Wang, J. (2021) · Aging Cell · doi:10.1111/acel.13358 · Cited by 64
“…reduction of the platelet activation- related proteins may affect hemostasis and maintain normal vascular function, which is consistent with the vascular risk factors of AD patients, such as diabetes, hypertension, atherosclerosis (Casserly & Topol, 2004; Helzner et al., 2009; Huo et al., 2003).”
ResultPannexin-1 Channels as Mediators of Neuroinflammation
Seo, J. H., Dalal, M. S., & Contreras, J. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105189 · Cited by 65
Metadata
- Authors
- Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., Lemere, C. A., Selkoe, D. J., & Stevens, B.
- Affiliations
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- University of California, San Francisco (US)
- Stanford Medicine (US)
- Broad Institute (US)
- Corresponding author
- Beja-Glasser, Victoria F.
- Nfonoyim, Bianca M.
- Stevens, Beth
- ORCID
- Venue
- Science
- Published
- 2016-05-06
- Volume
- 352
- Issue
- 6286
- Pages
- 712-716
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5094372
- OpenAlex
- W2314634699
- Cited by
- 3,343
- References
- 33
- Citations by year
- 2026: 415 · 2025: 391 · 2024: 384 · 2023: 388 · 2022: 324 · 2021: 363 · 2020: 306 · 2019: 260 · 2018: 240 · 2017: 198 · 2016: 69
- FWCI
- 140.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Edward R. and Anne G. Lefler Fellowship
- Coins for Alzheimer's Research Trust
- Fidelity Biosciences Research Initiative
- JPB Foundation
- National Institutes of Health (AG000222)
- National Institute of Neurological Disorders and Stroke-NIH (R01NS083845)
- National Institute on Aging-NIH (1RF1AG051496A)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Alzheimer's disease, synaptic loss, complement system, microglia, C1q, CR3, complement C3, soluble amyloid-beta oligomers, neuroinflammation, synaptic pruning, hippocampal long-term potentiation, phagocytosis, mouse model
- MeSH terms
- Disks Large Homolog 4 Protein, Alzheimer Disease, Animals, Cognition Disorders, Complement Pathway, Classical, Disease Models, Animal, Membrane Proteins, Phagocytosis, Synapses, Up-Regulation, Complement C1q, Macrophage-1 Antigen, Amyloid beta-Peptides, Synaptophysin, Microglia, Long-Term Potentiation, Mice, Knockout, Mice, Guanylate Kinases, CA1 Region, Hippocampal, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.